These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24618888)

  • 21. Profile of geriatric patients under DOTS in Revised National Tuberculosis Control Programme.
    Arora VK; Singla N; Sarin R
    Indian J Chest Dis Allied Sci; 2003; 45(4):231-5. PubMed ID: 12962456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Status of multidrug resistant tuberculosis (MDR-TB) among the Sahariya tribe of North Central India.
    Prakash R; Kumar D; Gupta VK; Jain S; Chauhan DS; Tiwari PK; Katoch VM
    J Infect Public Health; 2016; 9(3):289-97. PubMed ID: 26775848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and associated risk factors of drug-resistant tuberculosis in Thailand: results from the fifth national anti-tuberculosis drug resistance survey.
    Kamolwat P; Nateniyom S; Chaiprasert A; Disratthakit A; Mahasirimongkol S; Yamada N; Smithtikarn S
    Trop Med Int Health; 2021 Jan; 26(1):45-53. PubMed ID: 32997863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National anti-tuberculosis drug resistance study in Tanzania.
    Chonde TM; Basra D; Mfinanga SG; Range N; Lwilla F; Shirima RP; van Deun A; Zignol M; Cobelens FG; Egwaga SM; van Leth F
    Int J Tuberc Lung Dis; 2010 Aug; 14(8):967-72. PubMed ID: 20626940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
    Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B
    BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuberculosis in Poland in 2017.
    Korzeniewska- Koseła M
    Przegl Epidemiol; 2019; 73(2):211-226. PubMed ID: 31385679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Side effects--part of the package": a mixed methods approach to study adverse events among patients being programmatically treated for DR-TB in Gujarat, India.
    Jakasania A; Shringarpure K; Kapadia D; Sharma R; Mehta K; Prajapati A; Kathirvel S
    BMC Infect Dis; 2020 Dec; 20(1):918. PubMed ID: 33267826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002-2005.
    Cavanaugh JS; Kazennyy BY; Nguyen ML; Kiryanova EV; Vitek E; Khorosheva TM; Nemtsova E; Cegielski JP
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1069-74. PubMed ID: 22691694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi.
    Myneedu VP; Singhal R; Khayyam KU; Sharma PP; Bhalla M; Behera D; Sarin R
    J Epidemiol Glob Health; 2015 Dec; 5(4):365-73. PubMed ID: 25944154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are we justified in treating for multidrug-resistant tuberculosis based on positive follow-up smear results?
    Kumar RS; Kumar AM; Claassens M; Banurekha VV; Sekar G; Venkatesan P; Swaminathan S
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):449-53. PubMed ID: 24670701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology and control of tuberculosis in Victoria, a low-burden state in south-eastern Australia, 2005-2010.
    Lavender CJ; Globan M; Kelly H; Brown LK; Sievers A; Fyfe JA; Lauer T; Leslie DE
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):752-8. PubMed ID: 23676157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An epidemiological study of multi drug resistant tuberculosis cases registered under Revised National Tuberculosis Control Programme of Ahmedabad City.
    Bhatt G; Vyas S; Trivedil K
    Indian J Tuberc; 2012 Jan; 59(1):18-27. PubMed ID: 22670507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors leading to under-reporting of tuberculosis in the private sector in Korea.
    Hong SJ; Park YS; An H; Kang SM; Cho EH; Shin SS
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1221-7. PubMed ID: 22794136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.
    Abebe G; Abdissa K; Abdissa A; Apers L; Agonafir M; de-Jong BC; Colebunders R
    BMC Res Notes; 2012 May; 5():225. PubMed ID: 22574696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
    Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q
    BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A community-based TB drug susceptibility study in Mimika District, Papua Province, Indonesia.
    Kelly PM; Ardian M; Waramori G; Anstey NM; Syahrial H; Tjitra E; Bastian I; Maguire GP; Lumb R
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):167-71. PubMed ID: 16499255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug-resistant tuberculosis in the Northern Territory: A 10-year retrospective case series.
    Judge D; Krause V
    Commun Dis Intell Q Rep; 2016 Sep; 40(3):E334-E339. PubMed ID: 28278406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis.
    Goyal V; Kadam V; Narang P; Singh V
    BMC Public Health; 2017 Oct; 17(1):817. PubMed ID: 29041901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric TB Management under RNTCP: What and Why?
    Singh V
    Indian J Pediatr; 2019 Aug; 86(8):707-713. PubMed ID: 31250349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidrug-resistant tuberculosis in South Korea: a retrospective analysis of national registry data in 2011-2015.
    Lee M; Han J; Kim YR; Kwak N; Kim JH; Park O; Shin S; Moon HS; Kim HJ; Jang MJ; Yim JJ
    Int J Tuberc Lung Dis; 2019 Jul; 23(7):850-857. PubMed ID: 31439118
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.